Marksans Pharma - Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 29, 2009, has decided to conduct postal ballot to seek approval of the members of the Company:1. To sell / lease / dispose the Active Pharmaceutical Ingredient (API) plants of the Company located at Plot No. A88 & D10, Kurkumbh, MIDC, Pune, by way of an Ordinary Resolution under Section 293(1)(a) of the Companies Act, 1956, and... Marksans Pharma - Limited Review for the quarter ended Sep 30, 2009
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2009. Marksans Pharma - Financial Results for Sep 30, 2009
Marksans Pharma Ltd has informed BSE about the financial results for the Quarter ended September 30, 2009. Marksans Pharma - Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 30, 2009, has taken the following decisions, subject to other approvals whenever necessary and the prevailing market condition:1. To restructure business model of the Company, hiving off API division of the Company and to focus more on the Global Formulation business, and2. To raise capital through issue of equity or equity linked instruments upto Rs. 200 Crores. Marksans Pharma - Outcome of AGM
Marksans Pharma Ltd has informed BSE that the members at the 17th Annual General Meeting (AGM) of the Company held on September 25, 2009, inter alia, have passed the following resolutions: 1. Adoption of the Audited Balance Sheet as at March 31, 2009 & the Profit and Loss Account for the period ended March 31, 2009 and the Reports of the Directors and the Auditors thereon together.... Marksans Pharma - Change in Directorate
Marksans Pharma Ltd has informed BSE that Dr. Kim Tan, Director of the Company has retired (retirement by rotation) as a Director of the Company with effect from September 25, 2009 i.e. the date of the Annual General Meeting of the Company. Marksans Pharma fixes Book Closure for AGM
Marksans Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2009 to September 25, 2009 (both days inclusive) for the purpose of 17th Annual General Meeting (AGM) of the Company to be held on September 25, 2009. Marksans Pharma - Limited Review for the quarter ended June 30, 2009
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2009. Marksans Pharma - Financial Results for Jun 30, 2009
Marksans Pharma Ltd has informed BSE about the Financial Results for the Quarter ended June 30, 2009. Marksans Pharma - Press Release
Marksans Pharma Ltd has informed BSE regarding a Press Release dated July 21, 2009 titled "Marksans Pharma Limited announces USFDA approval of generic Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200 mg."Press Release:"Marksans Pharma Ltd hereby announces that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for generic Ibuprofen Capsules (Liquid Filled), 200 mg....